Programming cells to target brain tumours
Glioblastoma is the most common and most aggressive primary brain tumour, with an average survival…
Glioblastoma is the most common and most aggressive primary brain tumour, with an average survival…
Several types of conventional cancer therapies, such as radiotherapy or chemotherapy, destroy healthy cells along…
Researchers have gained a clearer insight into how common alterations to the structure of DNA…
New results from the phase III RATIONALE 306 trial show that tislelizumab plus chemotherapy significantly improved…
One in five breast cancer patients who undergo axillary lymph node dissection (ALND) will develop…
Survivorship care plans are an important tool to help cancer survivors transition out of active…
Fruit flies are allowing researchers to gain new insights into cachexia, a muscle-wasting condition responsible…
A new study led by University of California, Irvine (UCI), USA, researchers identifies two ways…
Researchers at Fred Hutchinson Cancer Research Center, USA, published findings in the journal JAMA Network…
Oncotarget published “CEA as a blood-based biomarker in anal cancer” which reported that the mean…